These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7705796)

  • 41. Radiocopper studies in patients with Wilson's disease and their relatives.
    Tauxe WN; Goldstein NP; Randall RV; Gross JB
    Am J Med; 1966 Sep; 41(3):375-80. PubMed ID: 5914113
    [No Abstract]   [Full Text] [Related]  

  • 42. [Dissociative action of copper on the polysomes in the rat liver and brain. A possible pathogenic mechanism of Wilson's disease].
    Hernández-Pérez O; Ballesteros LM; Méndez D; Rosado A
    Gac Med Mex; 1975 Sep; 110(3):205-11. PubMed ID: 1205062
    [No Abstract]   [Full Text] [Related]  

  • 43. A mathematical model for copper metabolism and its relation to Wilson's disease.
    Hazelrig JB; Owen CA; Ackerman E
    Am J Physiol; 1966 Nov; 211(5):1075-81. PubMed ID: 5924028
    [No Abstract]   [Full Text] [Related]  

  • 44. FURTHER studies on copper in Wilson's disease.
    Nutr Rev; 1955 Aug; 13(8):232-4. PubMed ID: 13244952
    [No Abstract]   [Full Text] [Related]  

  • 45. The influence of genetic and acquired liver defects on radio-copper turnover in Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1969 Jul; 2(7610):17-20. PubMed ID: 4182791
    [No Abstract]   [Full Text] [Related]  

  • 46. Copper toxicity, rats and Wilson's disease.
    Nutr Rev; 1975 Feb; 33(2):51-3. PubMed ID: 1124157
    [No Abstract]   [Full Text] [Related]  

  • 47. Can Wilson's disease patients be decoppered?
    Mason J; McQuaid A; Pheiffer H
    Lancet; 1989 Jun; 1(8652):1455. PubMed ID: 2567467
    [No Abstract]   [Full Text] [Related]  

  • 48. [Copper metabolism disorders as an attempt at explaining analogous pathological mechanisms in Wilson's syndrome and severe cases of liver cirrhosis].
    Pawlak J
    Wiad Lek; 1975 Jun; 28(12):1041-4. PubMed ID: 1136474
    [No Abstract]   [Full Text] [Related]  

  • 49. [Physiopathology of hepatolenticular degeneration (Wilson's disease)].
    Willvonseder R
    Wien Z Inn Med; 1973; 54(11-12):544-58. PubMed ID: 4804125
    [No Abstract]   [Full Text] [Related]  

  • 50. Abnormalities of the physiology of copper in Wilson's disease. 3. The excretion of copper.
    O'Reilly S; Weber PM; Oswald M; Shipley L
    Arch Neurol; 1971 Jul; 25(1):28-32. PubMed ID: 5146408
    [No Abstract]   [Full Text] [Related]  

  • 51. Value of urinary copper excretion after penicillamine challenge in the diagnosis of Wilson's disease.
    Martins da Costa C; Baldwin D; Portmann B; Lolin Y; Mowat AP; Mieli-Vergani G
    Hepatology; 1992 Apr; 15(4):609-15. PubMed ID: 1551638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Defective biliary excretion of copper in Wilson's disease.
    Frommer DJ
    Gut; 1974 Feb; 15(2):125-9. PubMed ID: 4820637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease.
    Osborn SB; Walshe JM
    Lancet; 1967 Feb; 1(7486):346-50. PubMed ID: 4163882
    [No Abstract]   [Full Text] [Related]  

  • 54. Dense Kayser-Fleischer ring in asymptomatic Wilson's disease (hepatolenticular degeneration).
    Sullivan CA; Chopdar A; Shun-Shin GA
    Br J Ophthalmol; 2002 Jan; 86(1):114. PubMed ID: 11801516
    [No Abstract]   [Full Text] [Related]  

  • 55. Metabolism of copper in Wilson's disease and in normal subjects; studies with Cu-64.
    EARL CJ; MOULTON MJ; SELVERSTONE B
    Am J Med; 1954 Aug; 17(2):205-13. PubMed ID: 13180528
    [No Abstract]   [Full Text] [Related]  

  • 56. Copper transport and excretion in normal subjects and in patients with Laennec's cirrhosis and Wilson's disease: a study with CU64.
    JENSEN WN; KAMIN H
    J Lab Clin Med; 1957 Feb; 49(2):200-10. PubMed ID: 13398686
    [No Abstract]   [Full Text] [Related]  

  • 57. COPPER and amino acids in Wilson's disease.
    Nutr Rev; 1954 Jul; 12(7):198-200. PubMed ID: 13176818
    [No Abstract]   [Full Text] [Related]  

  • 58. NEW HYPOTHESES concerning Wilson's disease.
    Nutr Rev; 1958 Feb; 16(2):37-8. PubMed ID: 13517688
    [No Abstract]   [Full Text] [Related]  

  • 59. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
    D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
    Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
    [No Abstract]   [Full Text] [Related]  

  • 60. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
    O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
    Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.